Canada markets close in 2 hours 54 minutes

Phathom Pharmaceuticals, Inc. (PHAT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.14-0.22 (-2.30%)
As of 01:03PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
682
682
0
0
0
Cost of Revenue
167
167
0
-
-
Gross Profit
515
515
0
-
-
Operating Expenses
Research Development
49,899
49,899
71,441
72,338
98,148
Selling General and Administrative
117,928
117,928
100,999
62,742
27,517
Total Operating Expenses
167,827
167,827
172,440
135,080
125,665
Operating Income or Loss
-167,312
-167,312
-172,440
-135,080
-125,665
Interest Expense
41,968
41,968
27,305
6,788
4,581
Total Other Income/Expenses Net
-188
-188
-110
-2,056
87
Income Before Tax
-201,592
-201,592
-197,723
-143,883
-129,068
Income from Continuing Operations
-201,592
-201,592
-197,723
-143,883
-129,068
Net Income
-201,592
-201,592
-197,723
-143,883
-129,068
Net Income available to common shareholders
-201,592
-201,592
-197,723
-143,883
-129,068
Basic EPS
-3.81
-
-5.05
-3.89
-3.88
Diluted EPS
-3.81
-
-5.05
-3.89
-3.88
Basic Average Shares
47,283
-
39,118
37,003
33,228
Diluted Average Shares
47,283
-
39,118
37,003
33,228